about
Moving towards effective therapeutic strategies for Neuronal Ceroid LipofuscinosisThe Possible Future Roles for iPSC-Derived Therapy for Autoimmune DiseasesInduced pluripotent stem cell-derived vascular smooth muscle cells: methods and applicationTherapeutic Potential of Stem Cells Strategy for Cardiovascular DiseasesRetinal pigment epithelium transplantation: concepts, challenges, and future prospectsDelayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke.Understanding the roadmaps to induced pluripotency.PHLDA3 impedes somatic cell reprogramming by activating Akt-GSK3β pathway.Immunogenicity and functional evaluation of iPSC-derived organs for transplantationKidney versus Liver Specification of SLC and ABC Drug Transporters, Tight Junction Molecules, and Biomarkers.Proteomics and glycoproteomics of pluripotent stem-cell surface proteins.Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotencyInduction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.Interaction between nonviral reprogrammed fibroblast stem cells and trophic factors for brain repair.Phosphorylation of ULK1 by AMPK is essential for mouse embryonic stem cell self-renewal and pluripotency.Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells.
P2860
Q26753109-5EB26EA8-D8C0-44D8-9081-CDF0E2C13048Q26799472-EE96810C-8016-4BD0-B799-7B510A24CDD0Q26853054-74566A7C-CC95-4BE0-AA9B-CC0C02FA83BFQ28068965-D67BE781-88D8-4722-B120-135B785567E2Q28083235-9E234FED-C285-49C3-BD38-B05DCCF8FA87Q33694696-A445EBFC-EA9B-4B59-AAA9-416D658FB9F7Q33720285-95DB4D72-E507-4D7D-95B5-EBFF4CE6CC6EQ33767315-AD3CC8E6-001F-489F-80B9-D414E48C2EAAQ36882692-4CBBCB2D-79DF-40A8-A56B-8B8E2247D856Q37062599-0D861399-B11F-4753-946C-22EE93D5BCFFQ38248378-30D02E66-FB30-4282-89FC-51B3DA3B7B30Q38290087-B869E5DD-0692-48F3-B00A-F46547A81035Q38632891-F97E17A0-5190-4D14-999F-6A3DD4CF3652Q38729706-FF57D0EC-7EF7-4756-816A-8D8B00284DD0Q39010783-6ADBE00C-FF9B-4FAA-86FF-44E7F23EED87Q48215511-8AFEE8CE-0147-4A18-A0E6-B6952C4B70EAQ50318447-D1ECB9FD-9651-4D67-97F3-8489A644985CQ50848812-8A8F92CD-ECB3-403F-B20D-7960E5FFBC9DQ52372446-A3D3CF0C-332D-4F9A-AD20-BF24567D236B
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical therapy using iPSCs: hopes and challenges
@ast
Clinical therapy using iPSCs: hopes and challenges
@en
type
label
Clinical therapy using iPSCs: hopes and challenges
@ast
Clinical therapy using iPSCs: hopes and challenges
@en
prefLabel
Clinical therapy using iPSCs: hopes and challenges
@ast
Clinical therapy using iPSCs: hopes and challenges
@en
P2860
P1476
Clinical therapy using iPSCs: hopes and challenges
@en
P2093
P2860
P304
P356
10.1016/J.GPB.2013.09.002
P50
P577
2013-09-21T00:00:00Z
2013-10-01T00:00:00Z